<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kakizaki M</submitter><funding>MEXT | Japan Society for the Promotion of Science</funding><funding>Shionogi Infectious Disease Research Promotion Foundation</funding><funding>MEXT | Japan Society for the Promotion of Science (JSPS)</funding><funding>The Mitsubishi Foundation</funding><funding>Japan Agency for Medical Research and Development</funding><funding>Astellas Foundation for Research on Metabolic Disorders</funding><funding>The Chemo-Sero-Therapeutic Research Institute</funding><funding>Japan Agency for Medical Research and Development (AMED)</funding><pagination>e0185324</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11784140</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>99(1)</volume><pubmed_abstract>A critical aspect of the mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is the protease-mediated activation of the viral spike (S) protein. The type II transmembrane serine protease TMPRSS2 is crucial for SARS-CoV-2 infection in lung epithelial Calu-3 cells and murine airways. However, the importance of TMPRSS2 needs to be re-examined because the ability to utilize TMPRSS2 is significantly reduced in the Omicron variants that spread globally. For this purpose, replication profiles of SARS-CoV-2 were analyzed in human respiratory organoids. All tested viruses, including Omicron variants, replicated efficiently in these organoids. Notably, all SARS-CoV-2 strains retained replication ability in TMPRSS2-gene knockout (KO) respiratory organoids, suggesting t</pubmed_abstract><journal>Journal of virology</journal><pubmed_title>The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids.</pubmed_title><pmcid>PMC11784140</pmcid><funding_grant_id>JP243fa627001</funding_grant_id><funding_grant_id>JP21gm1610005</funding_grant_id><funding_grant_id>23K07935</funding_grant_id><funding_grant_id>23K17416</funding_grant_id><funding_grant_id>JP23jf0126002</funding_grant_id><funding_grant_id>JPJSCCA20240006</funding_grant_id><pubmed_authors>Kakizaki M</pubmed_authors><pubmed_authors>Nagata N</pubmed_authors><pubmed_authors>Takeda M</pubmed_authors><pubmed_authors>Okura T</pubmed_authors><pubmed_authors>Hashimoto R</pubmed_authors><pubmed_authors>Ryo A</pubmed_authors><pubmed_authors>Kitai Y</pubmed_authors><pubmed_authors>Shirato K</pubmed_authors><pubmed_authors>Yamamoto T</pubmed_authors><pubmed_authors>Akahori Y</pubmed_authors><pubmed_authors>Katoh H</pubmed_authors><pubmed_authors>Takayama K</pubmed_authors></additional><is_claimable>false</is_claimable><name>The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids.</name><description>A critical aspect of the mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is the protease-mediated activation of the viral spike (S) protein. The type II transmembrane serine protease TMPRSS2 is crucial for SARS-CoV-2 infection in lung epithelial Calu-3 cells and murine airways. However, the importance of TMPRSS2 needs to be re-examined because the ability to utilize TMPRSS2 is significantly reduced in the Omicron variants that spread globally. For this purpose, replication profiles of SARS-CoV-2 were analyzed in human respiratory organoids. All tested viruses, including Omicron variants, replicated efficiently in these organoids. Notably, all SARS-CoV-2 strains retained replication ability in TMPRSS2-gene knockout (KO) respiratory organoids, suggesting t</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-04T23:11:39.495Z</modification><creation>2025-04-04T23:11:39.495Z</creation></dates><accession>S-EPMC11784140</accession><cross_references><pubmed>39601592</pubmed><doi>10.1128/jvi.01853-24</doi></cross_references></HashMap>